Alyeska Investment Group, L.P. Adma Biologics, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.67 - $2.95 $334,000 - $590,000	-200,000 Reduced 42.94%	265,820 $468,000
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $906,708 - $1.29 Million	-503,727 Reduced 51.95%	465,820 $908,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $1.38 Million - $2.53 Million	677,001 Added 231.42%	969,547 $2.32 Million
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $708,379 - $963,045	-292,719 Reduced 50.01%	292,546 $857,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $2.06 Million - $3.07 Million	585,265 New	585,265 $0

339

182M

1.72M

846K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.05B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.